Mindblown: a blog about philosophy.

Proleukin – Medicines Repurposing pathway update One important potential route to patients getting access to Proleukin is the NHS Medicines Repurposing scheme (MR).

”Proleukin has the potential to be a game changer for people living with MND/ALS. The Mirocals trial was funded by charitable donations and tax payers – there is no excuse for not getting Proleukin to patients as soon as possible” Nicola Waters – Patients United2EndMND Mirocals Open Letter In our Proleukin (Interleukin 2) rolling update…

”People and families have waited far too long for the hope of a treatment for MND. We demand the release of the Mirocals paper immediately and access to Proleukin.” Stephen Darby – Patients United2EndMND Proleukin (Interleukin 2) Update Being part of the MND community, readers will no doubt be aware of the recent social media…

”Proleukin will give me more time to be her Mother. More time to guide, nurture and love her. Without Proleukin I will die sooner than I need to. The delay in getting this drug to patients is unacceptable and we will not tolerate inaction. People with MND deserve and demand treatment” Emma Moss – Patients…

The MND Association has published a series of very informative questions and answers in relation to the exciting MND treatment candidate low dose Interleukin 2. You can read them here. Most importantly we await the full publication of the trial results.

On Friday 28th April the MND Association announced something very important for our community – preparation for the potential arrival of effective treatments with regulators, scientists, government and, of course, patients. Patients are working with the MND Association to ensure the fastest possible access to promising treatments, if and when they arrive. This is vital work and very timely.